Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby powyżej 18 roku życia.
- •Potwierdzona diagnoza raka trzustki z przerzutami, potwierdzona w ciągu 12 tygodni przed badaniem.
- •Ogólny stan zdrowia pozwalający na codzienne funkcjonowanie (grupa 0 lub 1 wg ECOG).
- •Osoby, które nie otrzymywały wcześniej żadnego leczenia przeciwnowotworowego.
- •Obecność zmian nowotworowych, które można zmierzyć.
- •Dobre wyniki badań krwi, wątroby i krzepnięcia.
✗ Disqualifies
- •Osoby, które nie mogą połykać tabletek.
- •Inny typ raka trzustki niż gruczolakorak (np. rak płaskonabłonkowy, rak neuroendokrynny).
- •Osoby z rakiem ograniczonym tylko do jednej okolicy, bez przerzutów.
- •Osoby z przerzutami do mózgu, które są objawowe lub aktywnie postępują i nie były leczone.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (59)
Clearview Cancer Institute
Huntsville, United States
City of Hope
Phoenix, United States
City of Hope
Duarte, United States
University of California San Diego
San Diego, United States
Poudre Valley Health Care, Inc
Fort Collins, United States
Rocky Mountain Cancer Centers
Lone Tree, United States
Medical Oncology Hematology Consultants
Newark, United States
Hematology Oncology Associates of the Treasure Coast
Port Saint Lucie, United States
Florida Cancer Specialists - South
Sarasota, United States
Florida Cancer Specialists - North
St. Petersburg, United States
Florida Cancer Specialists - East
West Palm Beach, United States
Piedmont Cancer Institute
Atlanta, United States
Piedmont Healthcare
Atlanta, United States
Illinois Cancer Specialists
Arlington Heights, United States
City of Hope
Chicago, United States
OSF Medical Center
Peoria, United States
University of Kansas Cancer Center
Fairway, United States
Maryland Oncology
Columbia, United States
Missouri Cancer Associates
Columbia, United States
Comprehensive Cancer Centers
Las Vegas, United States
Regional Cancer Care
Belleville, United States
Astera Cancer Care
East Brunswick, United States
NYU Langone Health
New York, United States
Memorial Sloan Kettering Cancer Center
New York, United States
FirstHealth of the Carolinas
Pinehurst, United States
University of Cincinnati Cancer Center
Cincinnati, United States
Taylor Cancer Research Center
Maumee, United States
Willamette Valley Cancer Institute
Eugene, United States
Oregon Health and Science University
Portland, United States
Thomas Jefferson University
Philadelphia, United States
Prisma Health
Greenville, United States
Avera Cancer Institute Research
Sioux Falls, United States
West Cancer Center
Germantown, United States
Sarah Cannon Research Institute
Nashville, United States
Tennessee Oncology
Nashville, United States
Texas Oncology - West Texas
Abilene, United States
Texas Oncology - Austin
Austin, United States
Texas Oncology - San Antonio
San Antonio, United States
Texas Oncology Gulf Coast
Webster, United States
Blue Ridge Cancer Care
Blacksburg, United States
Virginia Cancer Specialists
Fairfax, United States
University of Washington Fred Hutchinson Cancer Center
Seattle, United States
Northwest Cancer Specialists
Vancouver, United States
University of Wisconsin Carbone Cancer Center
Madison, United States
Nepean Cancer Care Centre
Kingswood, Australia
Calvary Mater Newcastle
Waratah, Australia
Genesiscare
Waratah, Australia
Icon Cancer Centre - Chermside
Chermside, Australia
Princess Alexandra Hospital
Woolloongabba, Australia
Cancer Research South Australia
Adelaide, Australia
Bayside Health
Frankston East, Australia
Fiona Stanley Hospital
Murdoch, Australia
Institute of Clinical Oncology
Tbilisi, Georgia
Caucasus Medical Centre
Tbilisi, Georgia
LTD "Multiprofile Clinic Consilium Medulla"
Tbilisi, Georgia
SLK-Kliniken Heilbronn GMBH
Heilbronn, Germany
University College London Hospitals
London, United Kingdom
Imperial College Healthcare NHS
London, United Kingdom
The Christie NHS Foundation
Manchester, United Kingdom
Trial contact
Immuneering Study Team
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.